You pay for the medication itself and nothing else
Oral Wegovy could enter India in 6 to 9 months Oral format materially expands addressable patients Especially relevant in India where injections face resistance 4 Cold Chain Advantage - Underrated Factor Oral GLP-1 does not require refrigeration Easier distribution Deeper semi-urban & rural penetration This alone expands the market size materially
Individuals who are pregnant, breastfeeding, or planning to become pregnant, unless approved by a healthcare provider
There are a lot of factors to consider, too many to list here
What the clinical trial data shows Weight loss SURMOUNT-5 SURMOUNT-5 enrolled 751 adults with obesity but without type 2 diabetes and assigned them to the maximum tolerated dose of either tirzepatide (10 mg or 15 mg) or semaglutide (1.7 mg or 2.4 mg) for 72 weeks
A good example of this is growth hormone secretagogues peptides that facilitate growth hormone secretion whose capacity to promote physical growth can trigger the growth and spread of tumors.18 For that reason, peptides such as sermorelin, tesamorelin, and CJC-1295 are contraindicated for people with active cancer, as well as those with a personal or familial history of cancer
